Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

βIII-tubulin overexpression in cancer: Causes, consequences, and potential therapies
Arun Kanakkanthara, John H. Miller
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1876, Iss. 2, pp. 188607-188607
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Microtubule Targeting Agents in Disease: Classic Drugs, Novel Roles
Linda Wordeman, Juan Jesus Vicente
Cancers (2021) Vol. 13, Iss. 22, pp. 5650-5650
Open Access | Times Cited: 103
βIII-Tubulin Gene Regulation in Health and Disease
Alastair Duly, Felicity C. L. Kao, Wee Siang Teo, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 41
Targeting hormone-resistant breast cancer cells with docetaxel: a look inside the resistance
Alexander M. Scherbakov, А. А. Башарина, Danila V. Sorokin, et al.
Cancer Drug Resistance (2023) Vol. 6, Iss. 1, pp. 103-115
Open Access | Times Cited: 11
Novel 8-Methoxycoumarin-3-Carboxamides with potent anticancer activity against liver cancer via targeting caspase-3/7 and β-tubulin polymerization
Ahmad Alzamami, Eman M. Radwan, Eman Abo-Elabass, et al.
BMC Chemistry (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 9
Microtubule-Interfering Drugs: Current and Future Roles in Epithelial Ovarian Cancer Treatment
Joan Tymon‐Rosario, Naomi Adjei, Dana M. Roque, et al.
Cancers (2021) Vol. 13, Iss. 24, pp. 6239-6239
Open Access | Times Cited: 20
Tubulin Isotypes: Emerging Roles in Defining Cancer Stem Cell Niche
Tessy Thomas Maliekal, Dhrishya Dharmapal, Suparna Sengupta
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 15
Synthesis and Biological Evaluation of Novel 2-Aroyl Benzofuran-Based Hydroxamic Acids as Antimicrotubule Agents
Elena Mariotto, M. Canton, Chiara Marchioro, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7519-7519
Open Access | Times Cited: 2
The Tubulin Code and Tubulin-Modifying Enzymes in Autophagy and Cancer
Daniela Trisciuoglio, Francesca Degrassi
Cancers (2021) Vol. 14, Iss. 1, pp. 6-6
Open Access | Times Cited: 18
Simple monocyclic pyrimidine analogs as microtubule targeting agents binding to the colchicine site
Shruti Choudhary, Krishna Kaku, Andrew J. Robles, et al.
Bioorganic & Medicinal Chemistry (2023) Vol. 82, pp. 117217-117217
Open Access | Times Cited: 6
β-Tubulin Isotype, TUBB4B, Regulates The Maintenance of Cancer Stem Cells
Dhrishya Dharmapal, Athira Jyothy, Amrutha Mohan, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 13
Targeting an Old Foe for Cancer: A Molecular Dynamics Perspective to Unravel the Specific Binding Nature of 2-Methoxy Estradiol to Human β-Tubulin Isotypes
Sonia Kumari, M. Elizabeth Sobhia
Journal of Chemical Information and Modeling (2024) Vol. 64, Iss. 10, pp. 4121-4133
Closed Access | Times Cited: 1
Dysregulation of Microtubule Nucleating Proteins in Cancer Cells
Pavel Dráber, Eduarda Dráberová
Cancers (2021) Vol. 13, Iss. 22, pp. 5638-5638
Open Access | Times Cited: 12
Synthesis, modeling, and biological evaluation of anti-tubulin indole-substituted furanones
Brianna M. Hurysz, Blake Evans, Reuben N. Laryea, et al.
Bioorganic & Medicinal Chemistry Letters (2023) Vol. 90, pp. 129347-129347
Open Access | Times Cited: 4
OSGIN1 is a novel TUBB3 regulator that promotes tumor progression and gefitinib resistance in non-small cell lung cancer
Xiaomeng Xie, Kyle Vaughn Laster, Jian Li, et al.
Cellular and Molecular Life Sciences (2023) Vol. 80, Iss. 9
Open Access | Times Cited: 4
Predictive and Prognostic Value of TUBB3, RRM1, APE1, and Survivin Expression in Chemotherapy-Receiving Patients with Advanced Non‑Small Cell Lung Cancer
Pritsana Raungrut, Suchanan Tanyapattrapong, Jirapon Jirapongsak, et al.
Asian Pacific Journal of Cancer Prevention (2023) Vol. 24, Iss. 9, pp. 3003-3013
Open Access | Times Cited: 4
Clinical and Molecular Features of Morpheaform Basal Cell Carcinoma: A Systematic Review
Santina Conte, Sarah Ghezelbash, Bonika Nallanathan, et al.
Current Oncology (2023) Vol. 30, Iss. 11, pp. 9906-9928
Open Access | Times Cited: 4
PRPF6 promotes metastasis and paclitaxel resistance of ovarian cancer via SNHG16/CEBPB/GATA3 axis
Han Wang, Yingying Zhou, SIYANG ZHANG, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2021) Vol. 29, Iss. 4, pp. 275-289
Open Access | Times Cited: 10
Sox2 and βIII-Tubulin as Biomarkers of Drug Resistance in Poorly Differentiated Sinonasal Carcinomas
Luis R. Lopez, Laura Fernández, Virginia N. Cabal, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 10, pp. 1504-1504
Open Access | Times Cited: 2
CD72, a new immune checkpoint molecule, is a novel prognostic biomarker for kidney renal clear cell carcinoma
Tian Lv, Yiming Wang, Zhiyuan Zhang, et al.
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 2
Unveiling microtubule dynamics in lung cancer: Recent findings and prospects for drug delivery and treatment
Megumi Nishitani Yukuyama, Aline de Souza, Mirla Anali Bazán Henostroza, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 89, pp. 105017-105017
Closed Access | Times Cited: 1
Multi‑dimensional analysis reveals NCKAP5L is a promising biomarker for the diagnosis and prognosis of human cancers, especially colorectal cancer
Yu Sha, Wenken Liang, Chune Mo, et al.
Oncology Letters (2023) Vol. 27, Iss. 2
Open Access | Times Cited: 1
Molecular Diagnostics of the Involvement of Visually Normal Mucosa in the Malignancy Process in Urothelial Bladder Cancer
Т. А. Богуш, А. А. Башарина, Z. M. Safarov, et al.
Molecular Biology (2022) Vol. 56, Iss. 4, pp. 592-599
Closed Access | Times Cited: 1
Conformation and energy investigation of microtubule longitudinal dynamic instability induced by natural products
Yanyan Chu, Zhenhua Tian, Mengke Yang, et al.
Chemical Biology & Drug Design (2022) Vol. 102, Iss. 3, pp. 444-456
Closed Access | Times Cited: 1
OSGIN1 is a novel TUBB3 regulator that promotes tumor progression and gefitinib resistance in non-small cell lung cancer
Xiaomeng Xie, Kyle Vaughn Laster, Jian Li, et al.
Research Square (Research Square) (2023)
Open Access
miR-31-mediated local translation at the mitotic spindle is important for early development
Carolyn M. Remsburg, Kalin D. Konrad, Nadezda A. Stepicheva, et al.
Research Square (Research Square) (2023)
Open Access
Page 1 - Next Page

Scroll to top